Work

A randomized, double-blind crossover study of change in post-dose lung function with a next generation propellant for metered dose inhalers in patients with asthma

Year: 2024

Type: conference-abstract

DOI: 10.1183/13993003.congress-2024.pa3914

Authors: Alan Bell, Mandeep Jassal, John Xu, David Petullo, Ibrahim Raphiou, Patrik Bondarov, Magnus Aurivillius, Roy A Pleasants

Institutions: AstraZeneca (United Kingdom), AstraZeneca (United States), AstraZeneca (Sweden), University of North Carolina at Chapel Hill, University of Michigan

Language: English

Topic: Inhalation and Respiratory Drug Delivery

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404098462

Cites:

Cited by:

Related to: 10